Literature DB >> 25451552

Decreased dopamine receptor 1 activity and impaired motor-skill transfer in Dyt1 ΔGAG heterozygous knock-in mice.

Fumiaki Yokoi1, Mai T Dang2, Jun Liu3, Jason R Gandre1, Kelly Kwon1, Robert Yuen4, Yuqing Li5.   

Abstract

DYT1 dystonia is a movement disorder caused by a trinucleotide deletion (ΔGAG) in DYT1 (TOR1A), corresponding to a glutamic acid loss in the C-terminal region of torsinA. Functional alterations in the basal ganglia circuits have been reported in both DYT1 dystonia patients and rodent models. Dyt1 ΔGAG heterozygous knock-in (KI) mice exhibit motor deficits and decreased striatal dopamine receptor 2 (D2R) binding activity, suggesting a malfunction of the indirect pathway. However, the role of the direct pathway in pathogenesis of dystonia is not yet clear. Here, we report that Dyt1 KI mice exhibit significantly decreased striatal dopamine receptor 1 (D1R) binding activity and D1R protein levels, suggesting the alteration of the direct pathway. The decreased D1R may be caused by translational or post-translational processes since Dyt1 KI mice had normal levels of striatal D1R mRNA and a normal number of striatal neurons expressing D1R. Levels of striatal ionotropic glutamate receptor subunits, dopamine transporter, acetylcholine muscarinic M4 receptor and adenosine A2A receptor were not altered suggesting a specificity of affected polytopic membrane-associated proteins. Contribution of the direct pathway to motor-skill learning has been suggested in another pharmacological rat model injected with a D1R antagonist. In the present study, we developed a novel motor skill transfer test for mice and found deficits in Dyt1 KI mice. Further characterization of both the direct and the indirect pathways in Dyt1 KI mice will aid the development of novel therapeutic drugs.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DYT1; Direct pathway; Dopamine receptor; Dystonia; Motor-skill transfer; TorsinA

Mesh:

Substances:

Year:  2014        PMID: 25451552      PMCID: PMC4286880          DOI: 10.1016/j.bbr.2014.11.037

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  65 in total

1.  Conditions for interference versus facilitation during sequential sensorimotor adaptation.

Authors:  O Bock; S Schneider; J Bloomberg
Journal:  Exp Brain Res       Date:  2001-06       Impact factor: 1.972

2.  Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons.

Authors:  Zhongfeng Wang; Li Kai; Michelle Day; Jennifer Ronesi; Henry H Yin; Jun Ding; Tatiana Tkatch; David M Lovinger; D James Surmeier
Journal:  Neuron       Date:  2006-05-04       Impact factor: 17.173

3.  Intermanual transfer of procedural learning after extended practice of probabilistic sequences.

Authors:  Karin C Japikse; Selam Negash; James H Howard; Darlene V Howard
Journal:  Exp Brain Res       Date:  2002-11-09       Impact factor: 1.972

4.  Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant.

Authors:  Gonzalo E Torres; Ava L Sweeney; Jean-Martin Beaulieu; Pullani Shashidharan; Marc G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

5.  An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 ΔGAG knock-in mice.

Authors:  Mai T Dang; Fumiaki Yokoi; Chad C Cheetham; Jun Lu; Viet Vo; David M Lovinger; Yuqing Li
Journal:  Behav Brain Res       Date:  2011-10-08       Impact factor: 3.332

6.  Adaptation to visuomotor transformations: consolidation, interference, and forgetting.

Authors:  John W Krakauer; Claude Ghez; M Felice Ghilardi
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

Review 7.  The pathophysiological basis of dystonias.

Authors:  Xandra O Breakefield; Anne J Blood; Yuqing Li; Mark Hallett; Phyllis I Hanson; David G Standaert
Journal:  Nat Rev Neurosci       Date:  2008-03       Impact factor: 34.870

8.  Neurotransmitter receptor analysis in transgenic mouse models.

Authors:  Caroline L Benn; Laurie A Farrell; Jang-Ho J Cha
Journal:  Methods Mol Biol       Date:  2004

9.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

10.  Pre-synaptic release deficits in a DYT1 dystonia mouse model.

Authors:  Fumiaki Yokoi; Chad C Cheetham; Susan L Campbell; J David Sweatt; Yuqing Li
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

View more
  17 in total

1.  Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice.

Authors:  Fumiaki Yokoi; Janneth Oleas; Hong Xing; Yuning Liu; Kelly M Dexter; Carly Misztal; Melinda Gerard; Iakov Efimenko; Patrick Lynch; Matthew Villanueva; Raul Alsina; Shiv Krishnaswamy; David E Vaillancourt; Yuqing Li
Journal:  Neurobiol Dis       Date:  2019-10-13       Impact factor: 5.996

2.  In vivo imaging reveals impaired connectivity across cortical and subcortical networks in a mouse model of DYT1 dystonia.

Authors:  Jesse C DeSimone; Marcelo Febo; Priyank Shukla; Edward Ofori; Luis M Colon-Perez; Yuqing Li; David E Vaillancourt
Journal:  Neurobiol Dis       Date:  2016-07-09       Impact factor: 5.996

3.  Mu opioid receptor knockout mouse: Phenotypes with implications on restless legs syndrome.

Authors:  Shangru Lyu; Mark P DeAndrade; Erica L Unger; Stefan Mueller; Alexander Oksche; Arthur S Walters; Yuqing Li
Journal:  J Neurosci Res       Date:  2020-05-19       Impact factor: 4.164

4.  Improved survival and overt "dystonic" symptoms in a torsinA hypofunction mouse model.

Authors:  Fumiaki Yokoi; Fangfang Jiang; Kelly Dexter; Bryan Salvato; Yuqing Li
Journal:  Behav Brain Res       Date:  2019-12-28       Impact factor: 3.332

5.  Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of DYT1 Dystonia.

Authors:  Vincenza D'Angelo; Valentina Castelli; Mauro Giorgi; Silvia Cardarelli; Ilaria Saverioni; Francesca Palumbo; Paola Bonsi; Antonio Pisani; Carmela Giampà; Roberto Sorge; Stefano Biagioni; Francesca R Fusco; Giuseppe Sancesario
Journal:  J Neurosci       Date:  2017-01-23       Impact factor: 6.167

6.  Hyperactivity, dopaminergic abnormalities, iron deficiency and anemia in an in vivo opioid receptors knockout mouse: Implications for the restless legs syndrome.

Authors:  Shangru Lyu; Mark P DeAndrade; Stefan Mueller; Alexander Oksche; Arthur S Walters; Yuqing Li
Journal:  Behav Brain Res       Date:  2019-07-31       Impact factor: 3.332

7.  BTBD9 and dopaminergic dysfunction in the pathogenesis of restless legs syndrome.

Authors:  Shangru Lyu; Atbin Doroodchi; Hong Xing; Yi Sheng; Mark P DeAndrade; Youfeng Yang; Tracy L Johnson; Stefan Clemens; Fumiaki Yokoi; Michael A Miller; Rui Xiao; Yuqing Li
Journal:  Brain Struct Funct       Date:  2020-05-28       Impact factor: 3.270

8.  The role of BTBD9 in the cerebral cortex and the pathogenesis of restless legs syndrome.

Authors:  Shangru Lyu; Hong Xing; Mark P DeAndrade; Pablo D Perez; Keer Zhang; Yuning Liu; Fumiaki Yokoi; Marcelo Febo; Yuqing Li
Journal:  Exp Neurol       Date:  2019-11-09       Impact factor: 5.330

9.  Probe the relationship between BTBD9 and MEIS1 in C. elegans and mouse.

Authors:  Shangru Lyu; Atbin Doroodchi; Yi Sheng; Mark P DeAndrade; Youfeng Yang; Yuning Liu; Michael A Miller; Rui Xiao; Yuqing Li
Journal:  Exp Results       Date:  2020-03-31

10.  Investigating the role of striatal dopamine receptor 2 in motor coordination and balance: Insights into the pathogenesis of DYT1 dystonia.

Authors:  Yuning Liu; Hong Xing; Fumiaki Yokoi; David E Vaillancourt; Yuqing Li
Journal:  Behav Brain Res       Date:  2021-01-18       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.